Ashwin Gollerkeri
Corporate Officer/Principal bei KYMERA THERAPEUTICS, INC.
Profil
Ashwin Gollerkeri is currently the Senior Vice President & Head-Development at Kymera Therapeutics, Inc. Previously, he held the same position at Array BioPharma, Inc. He completed his undergraduate degree at Northwestern University and his doctorate at Kansas City University of Medicine & Biosciences.
Aktive Positionen von Ashwin Gollerkeri
| Unternehmen | Position | Beginn |
|---|---|---|
| KYMERA THERAPEUTICS, INC. | Corporate Officer/Principal | 03.02.2021 |
Ehemalige bekannte Positionen von Ashwin Gollerkeri
| Unternehmen | Position | Ende |
|---|---|---|
| ARRAY TECHNOLOGIES, INC. | Corporate Officer/Principal | - |
Ausbildung von Ashwin Gollerkeri
| Kansas City University of Medicine & Biosciences | Doctorate Degree |
| Northwestern University | Undergraduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 1 |
|---|---|
| KYMERA THERAPEUTICS, INC. | Health Technology |
| Private Unternehmen | 1 |
|---|---|
Array BioPharma, Inc.
 Array BioPharma, Inc. Pharmaceuticals: MajorHealth Technology Array BioPharma, Inc. is a biopharmaceutical company. Its focus is on the discovery, development and commercialization of targeted small molecule drugs to treat patients afflicted with cancer and other high-burden diseases. The company's products are BRAFTOVI and MEKTOVI. Its portfolio includes Binimetinib, Selumetinib, Encorafenib, Filanesib, Ipatasertib, Varltinib, Danoprevir, ARRY-797, Larotrectinib, Tucatinib, ARRY-382, Motolimod, Prexasertib, GDC-0575, LOXO-292, LOXO-195, and AK-1830. The company was founded by Kevin Koch, Anthony D. Piscopio, K. C. Nicolaou, and David L. Snitman in 1998 and is headquartered in Boulder, CO. | Health Technology |
